# Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy

> **NCT01347060** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 17448 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** fluticasone propionate/salmeterol xinafoate combination
- **DRUG:** inhaled corticosteroids

## Key facts

- **NCT ID:** NCT01347060
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 17448 (ACTUAL)
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347060, "Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01347060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*